Dapoxetine ( Prilogy ™ ) has been under the public eye recently as patients around the world wait for it to be released to the public.
Dapoxetine is an SSRI medication which is used to treat premature ejaculation ( PE ). Janssen-Cilag, a
pharmaceutical company based in Sweden, have just recently submitted an marketing authorization for dapoxetineto be submitted there.
Many SSRI ( selective, serotonin, reuptake inhibitors ) are prescribed “off label”
to treat PE.
Combined results from two recent clinical trials of Dapoxetine, one taking place at the University of Minnesota showed promise for the drug’s future.
More than 2,600 men with ejaculation problems participated and the outcome showed efficacy for the new medication.
The creators of Dapoxetine, Johnson and Johnson hope to submit the drug for FDA approval for the second time in the next couple of months.
